(Q33924834)

30 July 2017

1 reference

title

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines (English)

1 reference

Japanese encephalitis virus

30 July 2017

0 references

Japanese encephalitis

1 reference

1 reference

Markoff L

1

1 reference

PubMed ID

10821970

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

30 July 2017

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

30 July 2017

18 Suppl 2

1 reference

30 July 2017

26-32

1 reference

Protection against Japanese encephalitis by inactivated vaccines

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Genotypes of Japanese encephalitis virus isolated in three states in Malaysia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Passive immunity for arbovirus infection. I. Artificially induced prophylaxis in man and mouse for Japanese (B) encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

Passive immunity for arbovirus infection. II. Quantitative aspects of naturally and artificially acquired protection in mice for Japanese (B) encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900038-4

7 January 2021

10.1016/S0264-410X(00)00038-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10821970